Iterum Therapeutics plc (ITRMF) Stock Competitors & Peer Comparison

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.9M. In comparison, CASIF has a market cap of 4.1M. Regarding current trading prices, ITRMF is priced at $0.04, while CASIF trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.05, whereas CASIF's P/E ratio is -0.08. In terms of profitability, ITRMF's ROE is +6.02%, compared to CASIF's ROE of +3.58%. Regarding short-term risk, ITRMF is less volatile compared to CASIF. This indicates potentially lower risk in terms of short-term price fluctuations for ITRMF.Check CASIF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.9M. In comparison, OCEA has a market cap of 118.6K. Regarding current trading prices, ITRMF is priced at $0.04, while OCEA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.05, whereas OCEA's P/E ratio is N/A. In terms of profitability, ITRMF's ROE is +6.02%, compared to OCEA's ROE of +0.08%. Regarding short-term risk, ITRMF is less volatile compared to OCEA. This indicates potentially lower risk in terms of short-term price fluctuations for ITRMF.Check OCEA's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.9M. In comparison, AFMDQ has a market cap of 1.6K. Regarding current trading prices, ITRMF is priced at $0.04, while AFMDQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.05, whereas AFMDQ's P/E ratio is N/A. In terms of profitability, ITRMF's ROE is +6.02%, compared to AFMDQ's ROE of -1.01%. Regarding short-term risk, ITRMF is more volatile compared to AFMDQ. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check AFMDQ's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.9M. In comparison, BIORQ has a market cap of 452. Regarding current trading prices, ITRMF is priced at $0.04, while BIORQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.05, whereas BIORQ's P/E ratio is N/A. In terms of profitability, ITRMF's ROE is +6.02%, compared to BIORQ's ROE of +1.22%. Regarding short-term risk, ITRMF is more volatile compared to BIORQ. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BIORQ's competition here